Literature DB >> 21821669

Noggin null allele mice exhibit a microform of holoprosencephaly.

Eva Lana-Elola1, Przemko Tylzanowski, Maarit Takatalo, Kirsi Alakurtti, Lotta Veistinen, Thimios A Mitsiadis, Daniel Graf, Ritva Rice, Frank P Luyten, David P Rice.   

Abstract

Holoprosencephaly (HPE) is a heterogeneous craniofacial and neural developmental anomaly characterized in its most severe form by the failure of the forebrain to divide. In humans, HPE is associated with disruption of Sonic hedgehog and Nodal signaling pathways, but the role of other signaling pathways has not yet been determined. In this study, we analyzed mice which, due to the lack of the Bmp antagonist Noggin, exhibit elevated Bmp signaling. Noggin(-/-) mice exhibited a solitary median maxillary incisor that developed from a single dental placode, early midfacial narrowing as well as abnormalities in the developing hyoid bone, pituitary gland and vomeronasal organ. In Noggin(-/-) mice, the expression domains of Shh, as well as the Shh target genes Ptch1 and Gli1, were reduced in the frontonasal region at key stages of early facial development. Using E10.5 facial cultures, we show that excessive BMP4 results in reduced Fgf8 and Ptch1 expression. These data suggest that increased Bmp signaling in Noggin(-/-) mice results in downregulation of the hedgehog pathway at a critical stage when the midline craniofacial structures are developing, which leads to a phenotype consistent with a microform of HPE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821669     DOI: 10.1093/hmg/ddr329

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  Noggin is required for early development of murine upper incisors.

Authors:  X Hu; Y Wang; F He; L Li; Y Zheng; Y Zhang; Y P Chen
Journal:  J Dent Res       Date:  2012-02-02       Impact factor: 6.116

Review 2.  Neural crest cell signaling pathways critical to cranial bone development and pathology.

Authors:  Yuji Mishina; Taylor Nicholas Snider
Journal:  Exp Cell Res       Date:  2014-02-06       Impact factor: 3.905

Review 3.  Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans.

Authors:  Anna Petryk; Daniel Graf; Ralph Marcucio
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-10-22       Impact factor: 5.814

4.  Molecular analysis of the Noggin (NOG) gene in holoprosencephaly patients.

Authors:  Kshitij Srivastava; Ping Hu; Benjamin D Solomon; Jeffrey E Ming; Erich Roessler; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-03-21       Impact factor: 4.797

Review 5.  TGF-β Family Signaling in Early Vertebrate Development.

Authors:  Joseph Zinski; Benjamin Tajer; Mary C Mullins
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 6.  Common mechanisms in development and disease: BMP signaling in craniofacial development.

Authors:  Daniel Graf; Zeba Malik; Satoru Hayano; Yuji Mishina
Journal:  Cytokine Growth Factor Rev       Date:  2015-11-24       Impact factor: 7.638

7.  Altered BMP-Smad4 signaling causes complete cleft palate by disturbing osteogenesis in palatal mesenchyme.

Authors:  Nan Li; Jing Liu; Han Liu; Shangqi Wang; Ping Hu; Hailing Zhou; Jing Xiao; Chao Liu
Journal:  J Mol Histol       Date:  2020-11-07       Impact factor: 2.611

8.  Enhanced BMP signaling prevents degeneration and leads to endochondral ossification of Meckel's cartilage in mice.

Authors:  Ying Wang; Yuqian Zheng; Di Chen; YiPing Chen
Journal:  Dev Biol       Date:  2013-07-23       Impact factor: 3.582

Review 9.  Molecular mechanisms of midfacial developmental defects.

Authors:  Akiko Suzuki; Dhruvee R Sangani; Afreen Ansari; Junichi Iwata
Journal:  Dev Dyn       Date:  2015-12-11       Impact factor: 3.780

10.  Multiple tissue-specific requirements for the BMP antagonist Noggin in development of the mammalian craniofacial skeleton.

Authors:  Maiko Matsui; John Klingensmith
Journal:  Dev Biol       Date:  2014-06-17       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.